NFKB1 and diffuse large B-cell lymphoma: To summarize, we find that cell-to-cell variability in NF-κB is consistent with the inherent molecular variability found in primary non-malignant B cells, while between cell populations there exists distinct expression of NF-κB components RelA and RelB that primes DLBCL cells to have distinct responses to the TME.